Key Insights

Highlights

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Active Sponsors

  • University Hospital, Ioannina1

Related Conditions

  • Covid 19 Associated Coagulopathy1
  • Covid19 Acute Respiratory Distress Syndrome1
  • Covid19 Pandemic1
  • Covid19 Coronavirus Disease 20191
  • Covid19 Pneumonia1

Activity Timeline